MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ovarian cancer is a leading cause of cancer death in women, necessitating improved detection and treatment strategies.
• MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer development, including ovarian cancer tumorigenesis.

Purpose of the Study:

• To investigate the role of miR-498 in ovarian cancer.
• To identify the molecular mechanisms by which miR-498 affects ovarian cancer cell behavior.

Main Methods:

• Quantitative real-time PCR to measure miR-498 expression in ovarian cancer tissues and cells.
• Cell proliferation assays to assess the functional impact of miR-498.
• Western blotting to analyze protein expression levels of cell cycle regulators (cyclin D1, p27) and FOXO3.
• Luciferase reporter assays to confirm direct targeting of FOXO3 by miR-498.

Main Results:

• miR-498 expression was significantly downregulated in ovarian cancer tissues and cells compared to normal controls.
• Ectopic expression of miR-498 inhibited ovarian cancer cell proliferation and blocked cell cycle progression at the S phase.
• miR-498 downregulation of cyclin D1 and upregulation of p27 contributed to the observed cell cycle arrest.
• FOXO3 was identified as a direct target of miR-498, with miR-498 regulating FOXO3 expression via its 3'-untranslated region.

Conclusions:

• miR-498 functions as a tumor suppressor in ovarian cancer.
• The miR-498/FOXO3 axis plays a critical role in regulating ovarian cancer cell proliferation.
• miR-498 represents a potential therapeutic target for ovarian cancer treatment.